rosiglitazone has been researched along with ramipril in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (67.86) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bosch, J; Gerstein, HC; Holman, R; Pogue, J; Yusuf, S | 1 |
| Scheen, AJ | 1 |
| Mohan, V | 1 |
| Bilous, R | 1 |
| Fövényi, J | 1 |
| Ruiz, J | 1 |
| Berkwits, M; Nathan, DM | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Abdul Rahman, AR; Ismail, AA; Ismail, SB; Naing, NN; Rahman, S | 1 |
| Goldberg, RB | 1 |
| McFarlane, SI; Provilus, A; Shin, JJ | 1 |
| Nitschmann, S; Standl, E | 1 |
| Roussel, R | 1 |
| Bosch, J; Budaj, A; Dagenais, GR; Escalante, A; Gerstein, HC; Hedner, T; Holman, R; Keltai, M; Lonn, E; McFarlane, S; McQueen, M; Pogue, J; Sheridan, P; Teo, K; Yusuf, S | 1 |
| Costa, B | 1 |
| Anand, SS; Gerstein, HC; McDonald, SD; Sheridan, P; Yusuf, S | 1 |
| Bosch, J; Dagenais, GR; Diaz, R; Gerstein, HC; Lonn, EM; Mohan, V; Sheridan, P; Smith, S; Yusuf, S | 1 |
| Baader, M; Breitschopf, K; Falk, E; Gerl, M; Kramer, W; Linz, W; Rütten, H; Schäfer, HL; Wohlfart, P | 1 |
| Braga, MF; Leiter, LA | 1 |
| Gerstein, HC; Hanley, AJ; Sheridan, P; Yusuf, S; Zinman, B | 1 |
| Anand, S; Bailey, SD; Diaz, R; Do, R; Engert, JC; Gerstein, HC; Keavney, B; Mohan, V; Montpetit, A; Xie, C; Yusuf, S | 1 |
| Anand, S; Boyko, EJ; Gerstein, HC; Mohan, V; Shaw, JE; Sheridan, P; Yusuf, S | 1 |
| Avezum, A; Bergenstal, RM; Bosch, J; Chiasson, JL; Garrido, M; Gerstein, HC; Joldersma, L; Jung, H; MacKinnon, I; Mohan, V; Rao, PV; Yusuf, S; Zinman, B | 1 |
| Bennett, PH; Crandall, JP; Edelstein, SL; Goldberg, RB; Kahn, SE; Knowler, WC; Mather, KJ; Mudaliar, S; Nathan, DM; Orchard, TJ; Temprosa, M; White, NH | 1 |
6 review(s) available for rosiglitazone and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Experiences of the DREAM trial].
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Incidence; Insulin Resistance; Male; Middle Aged; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2006 |
The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Angiopathies; Humans; Premedication; Ramipril; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2006 |
The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled?
Topics: Adult; Aged; Carotid Arteries; Clinical Trials as Topic; Diabetes Mellitus; Disease Progression; Female; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones | 2007 |
Role of renin-angiotensin system blockade in patients with diabetes mellitus.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Progression; Endothelium, Vascular; Humans; Ramipril; Renin-Angiotensin System; Rosiglitazone; Tetrazoles; Thiazolidinediones; Valine; Valsartan; Vasodilation; Ventricular Function | 2009 |
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
Topics: Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetes Complications; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Metformin; Microcirculation; Preventive Medicine; Ramipril; Risk Factors; Rosiglitazone; Treatment Outcome | 2019 |
12 trial(s) available for rosiglitazone and ramipril
| Article | Year |
|---|---|
Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.
Topics: Adult; Aged; Antihypertensive Agents; Body Mass Index; Body Size; Diabetes Mellitus; Diabetes, Gestational; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Life Style; Male; Middle Aged; Patient Selection; Pregnancy; Ramipril; Rosiglitazone; Thiazolidinediones | 2004 |
[DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones | 2006 |
Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Glucose Intolerance; Humans; Hypoglycemic Agents; Middle Aged; Pulsatile Flow; Ramipril; Rosiglitazone; Stroke Volume; Thiazolidinediones; Vascular Diseases | 2007 |
Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Prediabetic State; Ramipril; Rosiglitazone; Thiazolidinediones | 2007 |
[Three studies in type 2 diabetes: DREAM the wash-out results].
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hyperglycemia; Hypoglycemic Agents; Ramipril; Rosiglitazone; Thiazolidinediones | 2007 |
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Cardiovascular System; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Kidney; Male; Ramipril; Rosiglitazone; Thiazolidinediones | 2008 |
Dysglycemia and a history of reproductive risk factors.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Middle Aged; Ontario; Parity; Poverty; Pregnancy; Pregnancy Complications; Ramipril; Risk Factors; Rosiglitazone; Thiazolidinediones | 2008 |
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Carotid Arteries; Carotid Artery Diseases; Fasting; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Ramipril; Rosiglitazone; Single-Blind Method; Thiazolidinediones; Tunica Intima; Ultrasonography | 2009 |
Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones | 2010 |
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Ramipril; Risk Assessment; Rosiglitazone; Thiazolidinediones | 2010 |
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.
Topics: Aged; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Ramipril; Rosiglitazone; Thiazolidinediones | 2011 |
Incidence of diabetes following ramipril or rosiglitazone withdrawal.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Ramipril; Rosiglitazone; Substance Withdrawal Syndrome; Thiazolidinediones; Treatment Outcome | 2011 |
10 other study(ies) available for rosiglitazone and ramipril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
DREAM study and its impact on India.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Humans; Hypoglycemic Agents; India; Prediabetic State; Ramipril; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2006 |
DREAM and ADOPT: rosiglitazone does what it says on the packet.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Ramipril; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2007 |
[The DREAM of diabetes prevention].
Topics: Antihypertensive Agents; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2007 |
Trials that matter: rosiglitazone, ramipril, and the prevention of type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2007 |
[Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Male; Middle Aged; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2007 |
[The effectiveness in type 2 diabetes prevention: a forced landing to reality].
Topics: Acarbose; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Life Style; Metformin; Patient Education as Topic; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Rosiglitazone; Thiazolidinediones | 2008 |
The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Biomarkers; Cardiotonic Agents; Cell Line; Disease Progression; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Male; Molecular Structure; Nitric Oxide Synthase Type III; Oxazoles; PPAR alpha; Ramipril; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Survival Rate; Thiazolidinediones | 2009 |
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Topics: Diabetes Mellitus, Type 2; Edema; Female; Humans; Hypoglycemic Agents; Male; NFATC Transcription Factors; Polymorphism, Single Nucleotide; Ramipril; Rosiglitazone; Thiazolidinediones | 2010 |